Status:
COMPLETED
Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Respiratory Distress Syndrome
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE3
Brief Summary
To determine the effect of corticosteroids, administered 24 to 48 hours before parturition, on the incidence of neonatal respiratory distress syndrome (RDS) and to determine whether the therapy has an...
Detailed Description
BACKGROUND: Neonatal respiratory distress syndrome is one of the leading causes of disability and death in the newborn. In the United States, approximately 10 percent of all infants are premature, an...
Eligibility Criteria
Male and female fetuses and infants; pregnant women with anticipated premature delivery and gestational age between 26 and 37 weeks.
Key Trial Info
Start Date :
June 1 1976
Trial Type :
INTERVENTIONAL
End Date :
August 1 1983
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000563
Start Date
June 1 1976
End Date
August 1 1983
Last Update
April 27 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.